Recombinant Human Thrombopoietin (rhTPO)

DRUG2 trials

Sponsors

Nanfang Hospital, Southern Medical University, Shandong University

Conditions

Allogeneic Hematopoietic Stem Cell TransplantationDelayed Platelet EngraftmentImmune ThrombocytopeniaMyeloablative

Phase 3

An Investigation of rhTPO With Different Frequencies in the Management of ITP

CompletedNCT02139501

Shandong UniversityImmune Thrombocytopenia

Start: 2014-05-31End: 2015-01-31Updated: 2016-04-20

Phase 4

Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT

Nanfang Hospital, Southern Medical UniversityAllogeneic Hematopoietic Stem Cell Transplantation, Delayed Platelet Engraftment, Myeloablative

Start: 2010-06-30Target: 80Updated: 2015-10-09